Website-Related Compliance Risks: Accessibility, Tracking Technologies, and Notices
On-demand Originally aired on April 9, 2026
January 21, 2026 at 1:00 pm (EDT)
Webinar Information
Overview
Learning Objectives
Audience
Instructor
Format
Website-Related Compliance Risks: Accessibility, Tracking Technologies, and Notices
Is your health center’s website included in your 2026 Compliance Work Plan?
It should be. With the compliance date approaching for new website accessibility requirements under Section 504 of the Rehabilitation Act, evolving guidance on website tracking technologies, and required updates to website postings, your website should be a compliance priority.
This webinar will provide an overview of how to operationalize website compliance, with a focus on three critical components: ensuring accessible digital access for individuals with disabilities, understanding whether website tracking technologies require consent, and maintaining required notices that meet federal expectations.
This session will help health centers to identify gaps, prioritize compliance efforts, and build a sustainable approach to managing website-related risk.
CMOs
COOs
Compliance Officers
Risk Managers
Clinical Leadership
HIPAA Privacy Officers
HIPAA Security Officers
Identify key compliance requirements related to website accessibility under Section 504
Determine whether website consents and notices are required
Assess common website compliance gaps and develop strategies to mitigate risk
Dianne Pledgie
Principal
Dianne advises health care and non-profit organizations on the development and implementation of robust compliance programs.
Dianne also provides legal guidance on privacy, security and confidentiality matters, with particular focus on Health Insurance Portability and Accountability Act (HIPAA), 42 C.F.R. Part 2 and the Information Blocking Rule, including:
Advising clients on their obligations to protect patient records, respond to patient requests, and develop policies and procedures;
Reviewing business associate agreements, data use agreements, and patient consents related to the use and disclosure of protected health information and sensitive information; and